This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.
Scientific reports, 6, 29540
Citation
Klupp, Nerida L; Kiat, Hosen; Bensoussan, Alan; Steiner, Genevieve Z; Chang, Dennis H. (2016). A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome.. Scientific reports, 6, 29540. https://doi.org/10.1038/srep29540